Piramal Pharma's Sustainability Report Showcases Responsible Growth
Piramal Pharma's Approach to Sustainability
Piramal Pharma Limited (PPL) has unveiled its fourth annual Sustainability Report for the financial year 2025, embracing the theme 'Innovating Responsibly. Growing Sustainably.' This report encapsulates the company's progress and reinforced commitments under pivotal strategic pillars, namely Business Resilience, Quality & Excellence, Responsible Operations, and Stakeholder Centricity. By integrating science-led innovation and ethical responsibility, PPL aims to harmonize its mission of 'Doing Well and Doing Good' with sustainable growth.
Key Highlights from the Sustainability Report
PPL's Sustainability Report offers a comprehensive view of how the organization is intertwining responsible practices in its global operations. From strengthening governance and ethics to championing climate action and driving social impact via collaborations, PPL is dedicated to carving a sustainable path forward.
Business Resilience
Within the Business Resilience framework, PPL has made noteworthy strides in governance. Achieving 50% independent directors on its Board and exceeding statutory requirements for women representation, the company prides itself on zero data breaches and full compliance with its Code of Conduct training. Furthermore, over a quarter of critical suppliers have been assessed on sustainability criteria, with plans for enhanced capacity building by FY2026.
Quality & Excellence
PPL's commitment to Quality & Excellence is evidenced by 36 successful regulatory inspections, including those by the USFDA, and more than 165 customer audits completed globally. The ongoing digital transformation initiatives, notably through Catalyst NxGen (S/4HANA), have enhanced operational agility and scalability, with impressive customer satisfaction scores recorded at 85% for CDMO/PPS and 87% for Critical Care/PCC.
Responsible Operations Initiatives
PPL's dedication to Responsible Operations shines through tangible decarbonization efforts. This year alone, the company recorded a 6% reduction in Scope 1 & 2 emissions year-over-year and boosted renewable energy usage by 7.8%, achieving 20.2% of total energy sourced from bioenergy. Significant waste management initiatives have resulted in zero hazardous waste being sent to landfills, alongside ambitious targets for recycling non-hazardous waste.
Water Stewardship and Biodiversity
This year, PPL saved approximately 2.10 lakh kilolitres of freshwater through integrated water stewardship practices. The company has also initiated biodiversity projects, planting over 2,000 saplings and maintain 30% green cover at its facilities. A landmark project at their facility in Digwal has transitioned its coal-fired steam boiler to renewable biomass briquettes, marking a notable advancement in their sustainability journey.
Fostering Stakeholder Centricity
PPL's commitment to Stakeholder Centricity is reflected in its diversity, equity, and inclusion (DE&I) initiatives. With 30% women representation on the Board and 20% of the global workforce composed of women, the company has a strong focus on promoting gender equity. Additionally, every employee has received ESG training to ensure a unified commitment to sustainability.
Community Engagement and CSR Efforts
In collaboration with Piramal Foundation, PPL has proactively engaged in corporate social responsibility (CSR) initiatives, prominently affecting 112 aspirational districts. Fiscal Year 2025 has seen investments exceeding ?5.34 Crore in projects aimed at improving educational infrastructure, enhancing teaching capabilities, and addressing public health concerns. By leveraging employee volunteering, PPL amplifies its positive impact through health campaigns, community projects, and plantation drives.
Future Commitment to Sustainable Growth
Nandini Piramal, the Chairperson of Piramal Pharma Limited, emphasizes the importance of sustainability, stating, "In today's complex environment, shaped by climate change, regulatory shifts, and rising expectations of transparency and ethical conduct, sustainability has become central to long-term value creation." PPL’s inspiring journey towards decarbonization, renewable energy adoption, and commitment to diversity highlights its vision for growth that equitably supports both economic and environmental sustainability.
Frequently Asked Questions
What is the main theme of Piramal Pharma's Sustainability Report for FY2025?
The main theme is 'Innovating Responsibly. Growing Sustainably.', highlighting the company's commitment to responsible growth and sustainability.
What are the key pillars outlined in the report?
The key pillars are Business Resilience, Quality & Excellence, Responsible Operations, and Stakeholder Centricity.
How has Piramal Pharma improved its sustainability practices?
Piramal Pharma has notably reduced emissions, advanced renewable energy use, and implemented significant waste management solutions.
What initiatives has the company taken for community engagement?
Piramal Pharma has invested in educational infrastructure, health enhancements, and women’s empowerment initiatives in various districts.
How does the company incorporate diversity in its workforce?
Piramal Pharma has achieved 30% women representation on its Board and increased the number of women in its global workforce and campus hires.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
